01541 宜明昂科－Ｂ
按盘价 
14.000 0.000 (0.000%) | 日期 | 股东名称 | 披露原因 | 买入／卖出涉及 的股份数目 |
每股平均价 | 持有权益的 股份数目 |
占已发行 股本(%) |
| 05/09/2023 | 程义全 | 1701(L) | 16,560,270(L) | 7.28 | ||
| 05/09/2023 | 余治华 | 1701(L) | +19,263,240(L) | 19,263,240(L) | 13.23 | |
| 05/09/2023 | 于晓勇 | 1701(L) | +36,780,390(L) | 36,780,390(L) | 25.26 | |
| 05/09/2023 | 施毅 | 1701(L) | +27,721,575(L) | 27,721,575(L) | 12.18 | |
| 05/09/2023 | 陈飞 | 1701(L) | +7,967,925(L) | 7,967,925(L) | 5.47 | |
| 05/09/2023 | 于晓勇 | 1701(L) | +5,554,305(L) | 5,554,305(L) | 2.44 | |
| 05/09/2023 | 北京龙磐健康医疗投资中心(有限合夥) | 1701(L) | +19,263,240(L) | 19,263,240(L) | 13.23 | |
| 05/09/2023 | Jiaxing Changxian Enterprise Management L.P. (Limited Partnership) (嘉兴昶咸企业管理合夥企业(有限合夥)) | 1701(L) | +7,758,630(L) | 7,758,630(L) | 5.33 | |
| 05/09/2023 | Halo Biomedical Investment II Limited | 1701(L) | +18,000,000(L) | 18,000,000(L) | 7.91 | |
| 05/09/2023 | 上海张科领弋投资管理有限公司 | 1701(L) | +36,780,390(L) | 36,780,390(L) | 25.26 | |
| 05/09/2023 | Halo Biomedical Investment I Limited | 1701(L) | +18,000,000(L) | 18,000,000(L) | 7.91 | |
| 05/09/2023 | Jiaxing Hanning Enterprise Management Co., Ltd. (嘉兴翰泞企业管理有限公司) | 1701(L) | +15,178,477(L) | 15,178,477(L) | 10.42 | |
| 05/09/2023 | Jiaxing Hanning Enterprise Management Co., Ltd. (嘉兴翰泞企业管理有限公司) | 1701(L) | +15,178,478(L) | 15,178,478(L) | 6.67 | |
| 05/09/2023 | 上海领趋企业管理中心（有限合夥） | 1701(L) | +36,780,390(L) | 36,780,390(L) | 25.26 | |
| 05/09/2023 | GBA Fund Investment Limited | 1701(L) | +13,854,690(L) | 13,854,690(L) | 6.09 | |
| 05/09/2023 | Greater Bay Area Homeland Development Fund (GP) Limited | 1701(L) | +13,854,690(L) | 13,854,690(L) | 6.09 | |
| 05/09/2023 | Greater Bay Area Homeland Investments Limited | 1701(L) | +13,854,690(L) | 13,854,690(L) | 6.09 | |
| 05/09/2023 | Shanghai Liyao Investment Management Co., Ltd (上海礼曜投资管理有限公司) | 1701(L) | +7,967,925(L) | 7,967,925(L) | 5.47 | |
| 05/09/2023 | LAV GP V, L.P. | 1701(L) | +15,178,770(L) | 15,178,770(L) | 6.67 | |
| 05/09/2023 | 田文志 | 1701(L) | +68,269,973(L) | 68,269,973(L) | 29.99 | |
| 05/09/2023 | 田文志 | 1701(L) | +50,269,972(L) | 50,269,972(L) | 34.52 | |
| 05/09/2023 | 上海张科领弋升帆创业投资中心（有限合夥） | 1701(L) | +36,780,390(L) | 36,780,390(L) | 25.26 | |
| 05/09/2023 | 西藏龙磐管理咨询中心（有限合夥） | 1701(L) | +19,263,240(L) | 19,263,240(L) | 13.23 | |
| 05/09/2023 | Ho Yao | 1701(L) | 12,008,757(L) | 5.28 | ||
| 05/09/2023 | Jiaxing Changyu Enterprise Management L.P. (Limited Partnership) (嘉兴昶宇企业管理合夥企业(有限合夥)) | 1701(L) | +7,419,847(L) | 7,419,847(L) | 5.10 | |
| 05/09/2023 | 北京龙磐投资管理咨询中心（普通合夥） | 1701(L) | +19,263,240(L) | 19,263,240(L) | 13.23 | |
| 05/09/2023 | 西藏龙磐管理咨询中心（有限合夥） | 1701(L) | +19,263,240(L) | 19,263,240(L) | 13.23 | |
| 05/09/2023 | Greater Bay Area Homeland Investments Limited | 1701(L) | +13,854,690(L) | 13,854,690(L) | 6.09 | |
| 05/09/2023 | LAV ImmOn Hong Kong Limited | 1701(L) | +12,542,805(L) | 12,542,805(L) | 5.51 | |
| 05/09/2023 | LAV Asset Management (Hong Kong) Limited | 1701(L) | +27,721,575(L) | 27,721,575(L) | 12.18 | |
| 05/09/2023 | 上海张江科技创业投资有限公司 | 1701(L) | +10,862,055(L) | 10,862,055(L) | 7.46 | |
| 05/09/2023 | 上海张科领医企业管理中心（有限合夥） | 1701(L) | +36,780,390(L) | 36,780,390(L) | 25.26 | |
| 05/09/2023 | LAV ImmuneOnco Hong Kong Limited | 1701(L) | +15,178,770(L) | 15,178,770(L) | 6.67 | |
| 05/09/2023 | Halo Biomedical LP | 1701(L) | +18,000,000(L) | 18,000,000(L) | 7.91 | |
| 05/09/2023 | Shanghai Yongkan Investment Management Co.,Ltd. (上海永堪投资管理有限公司) | 1701(L) | +36,780,390(L) | 36,780,390(L) | 25.26 | |
| 05/09/2023 | Greater Bay Area Homeland Investments Limited | 1701(L) | +13,854,690(L) | 13,854,690(L) | 6.09 | |
| 05/09/2023 | LAV Biosciences Fund V, L.P. | 1701(L) | +15,178,770(L) | 15,178,770(L) | 6.67 | |
| 05/09/2023 | LAV Corporate V GP, Ltd. | 1701(L) | +15,178,770(L) | 15,178,770(L) | 6.67 | |
| 1 | ||||||
| 备注： | (L) - 长仓：包括 (1) 持有股份；(2) 透过持有丶沽出或发行金融合约，有权或有责任购买相关股份。 |
| (S) - 短仓：包括 (1) 借入股份；(2) 透过持有丶沽出或发行金融合约，有权或有责任沽出相关股份。 | |
| (P) - 可供借出的股份 | |
| 即时报价更新时间为 25/06/2024 13:21 | |
| 港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |